A deep and multi-variable analysis of patients with serious Covid-19 respiratory symptoms finds the condition associated with abnormal expression of one gene. . . . → Read More: AI Analysis Finds Serious Covid-19 Genetic Driver
|
|||||
       
  |
Venture investors worldwide continue to look past the pandemic as investments in start-up enterprises rose to new levels in the U.S., Asia, and elsewhere. . . . → Read More: Infographic – Q3 2021 Venture Funds Continue Banner Year 
A large-scale population genetics study finds several genetic variants associated with vertigo, a condition marked by dizziness and loss of balance. . . . → Read More: Population Study Finds Genetic Links for Vertigo 
An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company. . . . → Read More: AI-Designed Antibodies for Start-Up Sought in Open Call 
A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe. . . . → Read More: European Life Science Venture Fund Raises €472M 
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, equity, Europe, genomics, investment, licensing, life sciences, pharmaceuticals 
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M One comment - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, psychiatric, university, venture capital 
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger. . . . → Read More: Synthetic Antibody Company Goes Public in $230M Merger Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, Europe, investment, IPO, merger, pharmaceuticals 
A charitable foundation began work today supporting research on human longevity, with the goal of increasing lifespans to more than 120 years. . . . → Read More: Foundation Plans $1B for Longevity Research One comment - (Comments are closed) Finance biomedical, computer science, engineering, Europe, grant, life sciences, mathematics, medical device, pharmaceuticals, physical sciences 
A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections. . . . → Read More: Trial Underway Testing Cancer Drug as Covid-19 Therapy Comments are closed New products biomedical, biotechnology, clinical trials, Covid-19, Europe, India, life sciences, pharmaceuticals |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
